Data investigation

Do You Need a Prescription for Compounded Semaglutide?

Yes — but 503A and 503B do not carry the same requirement, and the gap between them is where the no-prescription pitches live. What each route actually asks for.

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
5 min read·3 citations

Yes. Every route that can lawfully put compounded semaglutide in your hands runs through a prescriber, and any seller telling you otherwise is describing a transaction that sits outside the pharmacy system rather than a shortcut through it. The more useful question is which route a seller is claiming, because the two federal ones do not carry the same requirement — and that gap is where the misleading pitches live.

The two routes ask for different things

Compounding happens under one of two sections of federal law, and they are not interchangeable. A 503A pharmacy has to be working from a valid prescription written for a specific, identified patient. A 503B outsourcing facility can do that too, but it may also ship against an order from a health-care provider — a hospital, say — that names no individual patient at all.[1]

What each compounding route requires
503A pharmacy503B outsourcing facility
Patient-specific prescriptionRequiredOne of two permitted bases
Provider order not naming a patientNot permittedPermitted
Subject to CGMP manufacturing rulesNoYes
What it means for you as a buyerA prescriber must have written it for youStill reaches you through a prescriber
Why the distinction matters to a reader, not just a lawyer. The 503B provider-order route is real, and a seller can point at it truthfully. What it is not is a route that ends with a vial arriving at your door with no clinician involved. It is how a facility supplies a clinic’s shelf, not how it supplies a stranger’s inbox.

So what is being sold without one?

Something that is not operating as a pharmacy. The sellers offering semaglutide or tirzepatide with no prescriber in the loop generally label the product as being for research, or as not for human consumption. That wording is not a product grade and it is not a technicality — it is the legal position the seller is taking, in writing, about what they are handing you.

FDA has acted against companies using exactly those labels on unapproved GLP-1 products, and has said it is aware of counterfeit Ozempic reaching buyers in the United States. Its instruction for anyone purchasing medication online is a single sentence long: use a state-licensed pharmacy.[2]

  • “No prescription needed” — there is no clinician accountable for your dose, your titration, or what happens if it goes wrong.
  • “Research use only” — the seller has told you in writing that this is not for you to inject. That statement is theirs, and it does not stop being theirs after you buy.
  • No named dispensing pharmacy — nothing to look up in a state board register, and no one to complain to.
  • Checkout with no intake at all — not a fast intake, no intake. A questionnaire that cannot be failed is a different problem, but no questionnaire is a clearer one.

A quick consult is still a consult

Plenty of legitimate telehealth runs on an asynchronous questionnaire rather than a video visit, and that is lawful in most of the country. The thing to check is not how long it took but whether a named, licensed prescriber signed off, and whether a named pharmacy dispensed. Both details should be findable without asking. Where they are not, we say so in the provider register.

The shortage answer has expired. If a seller explains its prescription-free model by pointing at the GLP-1 shortages, that reasoning ran out in 2025 — and it never licensed selling without a prescriber in the first place. Our explainer on which GLP-1s can still be compounded sets out what actually changed and when.[3]

What to ask, in order

  1. Who is the prescriber, and are they licensed in my state? A name you can check, not “our medical team”.
  2. Which pharmacy dispenses it? If the answer is a partner network with no name, that is the answer.
  3. Is this the approved product or a compounded one? If compounded, on what basis now that the shortages have closed?
  4. What happens if I have a reaction? A seller with no clinician has no answer to this, and the absence of an answer is the finding.

Frequently Asked Questions

References

  1. 1.U.S. Food and Drug Administration Human Drug Compounding Laws FDA Human Drug Compounding. 2026. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  2. 2.U.S. Food and Drug Administration FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss FDA Drug Safety and Availability. 2026. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  3. 3.U.S. Food and Drug Administration FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize FDA Drug Alerts and Statements. 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize

Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means

"Research use only" is the seller's legal position on what they are handing you, not a grade — and it removes the licensed dispenser, the accountable prescriber and every route to recourse.

7 min read

Compounded Semaglutide and Tirzepatide Are Ending: What to Do Next

The federal permission that made large-scale GLP-1 compounding lawful has closed. Three routes remain, one to avoid, and the questions to ask before you move.

6 min read

Compounded Semaglutide vs Ozempic and Wegovy: What Is Actually Different

Compounded semaglutide can contain the same molecule as Ozempic and Wegovy, but the formulation, the concentration, the dose ladder and the adverse-event record are not the same thing at all.

9 min read

Compounded Tirzepatide Side Effects: The Drug, and the Vial

Most compounded tirzepatide side effects are tirzepatide side effects, documented in the approved product's label and trials. A smaller set comes from the preparation — a pharmacy-set concentration, added ingredients, and an adverse-event pathway that may never count your report.

10 min read

GLP-1 Eye Risks: Diabetic Retinopathy and NAION Are Not the Same Thing

Two distinct eye questions get merged into one headline. Diabetic retinopathy complications are on the semaglutide label and trace to blood sugar falling fast; NAION is a separate optic-nerve signal that Europe labeled in June 2025 and US labeling still does not mention.

12 min read

GLP-1 Thyroid Cancer Risk: What the Boxed Warning Actually Says

Every semaglutide and tirzepatide label carries a boxed warning about thyroid C-cell tumors. It comes from rodent studies, the labels themselves say the human relevance is undetermined, and the human research published since does not agree with itself.

11 min read

Where to get tirzepatide (Mounjaro / Zepbound) online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.8

Gala

Moving between compounded and brand without changing seller

7.5

Synergy Rx

Knowing which pharmacy fills the vial — it names Belmar Pharmacy

8.5

Strut Health

Semaglutide at $99/month, 48% under the register median